Isabel Daher received her Bachelor of Science in Microbiology and Cell Science from the University of Florida and has experience across virology, immunology, and gene editing.

At the National Cancer Institute, she studied viral pathogenesis using a mouse model of oncogenic viral infection. She has spent the past three years as an R&D Scientist at MaxCyte, where she has helped develop novel workflows on the MaxCyte ExPERT platform.

More recently, Isabel contributed to the development and launch of the ExPERT DTx™, supporting high-throughput screening applications in cell therapy and bioprocessing.